Additional information
| Active substance | Gonadorelin |
|---|---|
| Formula | C55H75N17O13 |
| Side effects | Headache, flushing, nausea, abdominal pain, injection site reactions |
| Effects | Increases levels of LH and FSH, leading to stimulation of testosterone in men and ovulation in women |
| Dosage (sports) | Not typically used for sports enhancement due to its specific hormonal effects |
| Dosage (medical) | Typically 100 mcg injected intravenously or subcutaneously |
| Half-life | 2-10 minutes |
| Main action | Stimulates the release of gonadotropins (LH and FSH) from the anterior pituitary gland |
| Substance class | Peptide hormone |
| Chemical name | Gonadorelin |
| Storage conditions | Store refrigerated at 2-8В°C |
| Trade name | Factrel, Lutrelef |
| Blood pressure | No significant effect |
| WAREHOUSE | International Warehouse 3 |
| Also known as | Luteinizing Hormone-Releasing Hormone (LHRH), Gonadotropin-Releasing Hormone (GnRH) |
| Lab Test | Can influence LH and FSH levels in blood tests |
| Hepatotoxicity | None reported |
| Water Retention | Minimal |
| Use in sports | Rare, mainly investigated for potential misuse in manipulating hormone levels in sports where hormone checks are implemented |
| Manufacturer | Ultima Peptides |
Reviews
There are no reviews yet.